News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
GNI Ltd. Announces Approval for TSE Mothers Market Listing
July 31, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
TOKYO--(BUSINESS WIRE)--GNI Ltd., a biopharmaceutical company in Asia, announced that the Company received approval today from the Tokyo Stock Exchange Inc. (“TSE”) to list its shares on the Mothers market of the TSE.
Twitter
LinkedIn
Facebook
Email
Print
Asia
MORE ON THIS TOPIC
China
Lilly bets $3B+ to add China’s Haisco to growing list of partners in five-program pact
June 2, 2026
·
1 min read
·
Tristan Manalac
China
Big Pharma makes ‘creative effort’ to fold Chinese assets into pipelines
June 2, 2026
·
2 min read
·
Tristan Manalac
Lung cancer
ASCO: Kelun-Merck ADC shines with differentiated overall survival in first-line lung cancer
June 1, 2026
·
2 min read
·
Nick Paul Taylor
Immuno-oncology
ASCO: Akeso’s VEGF/PD-1 boosts lung cancer survival, relieving pressure on US partner Summit
May 31, 2026
·
3 min read
·
Annalee Armstrong
